 |
 |

Harbinger of Fluoroquinolone Resistance
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
The recent article by Lautenbach et al1 has raised concerns regarding the emerging problem of fluoroquinolone antibiotic resistance, and most important, demonstrates the potential gravity of fluoroquinolone overuse. We concur that strategies to reduce inappropriate fluoroquinolone utilization are clearly important. However, little is known whether the recent rise in fluoroquinolone resistance is related to increasing prescription rate as influenced by the industrial advertisements.
Given the fact that primary care physicians receive medical journals with the most advertisements,2 we evaluated the patterns of pharmaceutical advertisements for antibiotics in 4 major journals targeted for family practitioners (American Family Physician, Canadian Family Physician, Journal of Family Practice, and Postgraduate Medicine). We confined our survey of pharmaceutical advertisements to antibacterial agents. To account for monthly variations in advertising budgets, we randomly selected 4 months (January, April, July, and October) for each journal between calendar years 1984 and 2002. Among . . . [Full Text of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Fluoroquinolone Utilization in the Emergency Departments of Academic Medical Centers: Prevalence of, and Risk Factors for, Inappropriate Use
Ebbing Lautenbach, Lori A. Larosa, Nishaminy Kasbekar, Helen P. Peng, Richard J. Maniglia, and Neil O. Fishman
Arch Intern Med. 2003;163(5):601-605.
ABSTRACT
| FULL TEXT
|